Aligos Therapeutics, Inc. ALGS
4.37 USD +0.30 (+7.37%)
Nov 9, 2026, 2:00 PM EST
4.00 Day range 4.65
3.98 52-week range 13.69
- YTD
- -53.11%
- 1 year
- -38.19%
ALGS revenue history
Revenue is income from the company’s ordinary business activities.
2,186,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 2,186,000 | -1,759,000 | -44.59% |
| FY 2024 | 2024-12-31 | 3,945,000 | -11,584,000 | -74.60% |
| FY 2023 | 2023-12-31 | 15,529,000 | 1,622,000 | 11.66% |
| FY 2022 | 2022-12-31 | 13,907,000 | 9,548,000 | 219.04% |
| FY 2021 | 2021-12-31 | 4,359,000 | 4,359,000 | Not meaningful |
| FY 2020 | 2020-12-31 | 0 | 0 | Not meaningful |
| FY 2019 | 2019-12-31 | 0 | 0 | Not meaningful |
| FY 2018 | 2018-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-05-22T14:43:01.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.